Corrigendum: Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer

Front Genet. 2022 Jul 22:13:973325. doi: 10.3389/fgene.2022.973325. eCollection 2022.

Donglin Lai^{1

2}, Lin Tan³, Xiaojia Zuo¹, DingSheng Liu¹, Deyi Jiao⁴, Guoqing Wan¹, Changlian Lu¹, Dongjie Shen⁵, Xuefeng Gu^{1

2

4}

¹ Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.
² School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
³ The Affiliated Zhuzhou Hospital Xiangya Medical College CSU, Zhuzhou, China.
⁴ School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, China.
⁵ Department of General Surgery, Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fgene.2021.798612.].

Keywords: chemotherapy; ferroptosis; immunotherapy; lncRNA; prognostic; stomach cancer.